Coverage
Filings
Orion's collaboration partner Bayer announced U.S. FDA approval for darolutamide, an androgen receptor inhibitor (ARi), for metastatic hormone-sensitive prostate cancer (mHSPC).
| 25 Feb 2008 |
| Orion Group Financial Review of 2007 | 7 Feb 2008 |
| Matters to be handled at Orion's AGM on 25 March 2008 | 7 Feb 2008 |
| Orion sues Sun Pharmaceuticals in the U.S. to enforce Orion's U.S. Patent No. 5,446,194 covering its proprietary drug Stalevo® | 7 Feb 2008 |
| Orion: Annual Summary of Stock Exchange Releases and Announcements published in 2007 | 7 Feb 2008 |